We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
626
DELISTED
Cymabay Therapeutics
CBAY
| $8.32M | 0.02% |
1,450,000
| – | – |
|
|
NLSN
627
DELISTED
Nielsen Holdings plc
NLSN
| $8.29M | 0.02% |
397,420
-1,211
| -0.3% | -$19.7K |
|
628
Coherent
COHR
$65.4B
| $8.21M | 0.02% |
108,095
-308,000
| -74% | -$18.3M |
|
|
GRA
629
DELISTED
W.R. Grace & Co.
GRA
| $8.21M | 0.02% |
+149,724
| New | +$7.54M |
|
|
AKUS
630
DELISTED
Akouos Inc
AKUS
| $8.03M | 0.02% |
405,000
-64,000
| -14% | -$1.25M |
|
631
DXC Technology
DXC
$1.77B
| $7.92M | 0.02% |
307,578
+14,400
| +5% | +$307K |
|
632
Regency Centers
REG
$14.1B
| $7.88M | 0.02% |
172,900
-6,700
| -4% | -$288K |
|
633
News Corp Class A
NWSA
$16.1B
| $7.82M | 0.02% |
435,206
-1,528
| -0.3% | -$24.6K |
|
634
eBay
EBAY
$48.9B
| $7.79M | 0.02% |
155,100
-87,100
| -36% | -$4.45M |
|
635
Zions Bancorporation
ZION
$10.3B
| $7.76M | 0.02% |
178,586
-7,000
| -4% | -$259K |
|
636
United Rentals
URI
$72.4B
| $7.71M | 0.02% |
+33,261
| New | +$7.03M |
|
637
Huntington Ingalls Industries
HII
$12.7B
| $7.47M | 0.02% |
43,818
-1,800
| -4% | -$286K |
|
638
Black Diamond Therapeutics
BDTX
$110M
| $7.47M | 0.02% |
233,000
+88,000
| +61% | +$2.89M |
|
639
Warrior Met Coal
HCC
$4.73B
| $7.46M | 0.02% |
+350,000
| New | +$6.15M |
|
640
Franklin Resources
BEN
$17.3B
| $7.46M | 0.02% |
298,300
+139,100
| +87% | +$3.11M |
|
641
Hewlett Packard
HPE
$69.4B
| $7.42M | 0.02% |
625,836
-174,200
| -22% | -$1.83M |
|
642
Visteon
VC
$2.75B
| $7.36M | 0.02% |
58,614
-376,883
| -87% | -$39.7M |
|
643
Xcel Energy
XEL
$48.1B
| $7.35M | 0.02% |
110,186
-472,200
| -81% | -$32.9M |
|
644
Microchip Technology
MCHP
$40.4B
| $7.33M | 0.02% |
+106,200
| New | +$6.61M |
|
|
PARA
645
DELISTED
Paramount Global Class B
PARA
| $7.3M | 0.02% |
195,971
-1,287,500
| -87% | -$41.3M |
|
646
Robert Half
RHI
$4.16B
| $7.28M | 0.02% |
116,500
-5,700
| -5% | -$340K |
|
|
KIN
647
DELISTED
Kindred Biosciences, Inc.
KIN
| $7.22M | 0.02% |
1,675,000
| – | – |
|
|
SPRB
648
Spruce Biosciences
SPRB
$128M
| $7.06M | 0.02% |
+3,873
| New | +$6.42M |
|
649
Invesco
IVZ
$14B
| $6.99M | 0.02% |
401,269
-16,000
| -4% | -$246K |
|
650
Kimco Realty
KIM
$16.4B
| $6.99M | 0.02% |
465,863
-18,500
| -4% | -$245K |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.